Improving the quality of drug research or simply increasing its cost? An evidence-based study of the cost for data monitoring in clinical trials

British Journal of Clinical Pharmacology

Volumn 71, Issue 3, 2011, Pages 467-470

  Pronker, Esther ^a   Geerts, Bart F ^b   Cohen, Adam ^c   Pieterse, Herman ^d  

^a Leiden University Medical Centre ^*  (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

^d Profess Medical Consultancy BV   (Netherlands)

Author keywords

Clinical data management; Clinical research and sponsor query queries; Contract research organization

Indexed keywords

ARTICLE; CLINICAL STUDY; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DRUG RESEARCH; INFORMATION PROCESSING; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZATION;

CLINICAL TRIALS, PHASE I AS TOPIC; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; DRUG EVALUATION; HUMANS; PRACTICE GUIDELINES AS TOPIC; RESEARCH DESIGN;

EID: 79251630023     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2010.03839.x     Document Type: Article

References (9)

1. Shuchman M. Commercializing clinical trials - risks and benefits of the CRO boom. N Engl J Med 2007; 357: 1365-8.
2. Hughes B. 2007 FDA drug approvals: a year of flux. Nat Rev Drug Discov 2008; 7: 107-9.
3. Califf RM. Clinical trials bureaucracy: unintended consequences of well-intentioned policy. Clin Trials 2006; 3: 496-502.
4. Rondel RK, Varley SA, Webb CF. Clinical Data Management. Chichester: John Wiley and Sons, 2000.
5. ICH Topic E 6 (R1) Guideline for Good Clinical Practice: CPMP/ICH/135/95. European Medicines Agency. July 2002. Available at (last accessed 19 November 2010).
6. Promasys BV. Promasys for Windows; User Manual. Leiden Bio Science Park: CHDR, 2007.
7. Prokscha S. Practical Guide to Clinical Data Management. 2nd edn. FL, USA: Taylor and Francis group, 2007.
8. Pieterse H. The Future of Computerization at the Investigator Site. Amsterdam: Health Information Initiaives in the Netherlands, 1998.
9. Ratti E, Trist D. The continuing evolution of the drug discovery process in the pharmaceutical industry. Farmaco 2001; 56: 13-9.